Evicenter
Verzenio (abemaciclib) in HR-positive HER2-negative early breast cancer
Manufacturer
Lilly USA, LLC
Prescribing information
Verzenio (opens in a new tab)
Questions
27
Last updated

All questions

Dosing and administration: Verzenio (abemaciclib) in HR-positive HER2-negative early breast cancer

4 questions · 3 sources

Dosing

What is the Verzenio dose for early breast cancer?

How is the Verzenio dose reduced for side effects?

Note: For early breast cancer, Verzenio is given in combination with endocrine therapy (tamoxifen or an aromatase inhibitor), the second column of Table 1. The monotherapy column applies to an advanced or metastatic breast cancer indication (section 1.2 of the Prescribing Information).

Treatment duration

How long is Verzenio taken for early breast cancer?

Note: The second passage describes the monarchE trial in the Clinical Studies section of the Prescribing Information.

Treatment combinations

Do premenopausal women and men on Verzenio plus an aromatase inhibitor need a GnRH agonist?